SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

NCT07141329 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Supernus Pharmaceuticals, Inc.